NuSirt Biopharma
Menu

Home
About Us
Contact
Disease Areas
Healthcare Professionals
How NuSirt Biopharma hopes to build a life science presence in Nashville
Intellectual Property
Investor Relations
Landing Page
Login
Media
Nashville-based pharmaceutical company readies for human trials
NuSirt Biopharma Launches First Clinical Trial
NuSirt Biopharma Technology Presented at American Diabetes Association Scientific Sessions
Product Pipeline
R&D
Research Platform
Scientific Papers
Scientific Papers

Home
About Us
R&D
Investor Relations
- Intellectual Property
- Scientific Papers
Healthcare Professionals
Media
Contact

Login

NS-0200 (Leucine-Metformin-Sildenafil) Reduces Weight and Improves Metabolic Parameters in Adults

NS-0200 (Leucine-Metformin-Sildenafil) Reduces Weight and Improves Metabolic Parameters in Adults

Leave a comment |

NuSirt Biopharma – Better medicine...our dedication. © 2015. All Rights Reserved.

Powered By: SnapShot